ATE284709T1 - Virale chimären aus caev und hiv-1 genetischen elementen - Google Patents
Virale chimären aus caev und hiv-1 genetischen elementenInfo
- Publication number
- ATE284709T1 ATE284709T1 AT99919756T AT99919756T ATE284709T1 AT E284709 T1 ATE284709 T1 AT E284709T1 AT 99919756 T AT99919756 T AT 99919756T AT 99919756 T AT99919756 T AT 99919756T AT E284709 T1 ATE284709 T1 AT E284709T1
- Authority
- AT
- Austria
- Prior art keywords
- hiv
- chiv
- caev
- genetic elements
- provides
- Prior art date
Links
- 241000713772 Human immunodeficiency virus 1 Species 0.000 title abstract 3
- 241000713756 Caprine arthritis encephalitis virus Species 0.000 title abstract 2
- 230000002068 genetic effect Effects 0.000 title 1
- 230000003612 virological effect Effects 0.000 title 1
- 230000002163 immunogen Effects 0.000 abstract 3
- 230000028993 immune response Effects 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 230000004936 stimulating effect Effects 0.000 abstract 2
- 239000003937 drug carrier Substances 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 210000004698 lymphocyte Anatomy 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 241001430294 unidentified retrovirus Species 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16041—Use of virus, viral particle or viral elements as a vector
- C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Plant Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Hematology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8365298P | 1998-04-30 | 1998-04-30 | |
| US09/302,171 US6602505B2 (en) | 1998-04-30 | 1999-04-29 | Viral chimeras comprised of CAEV and HIV-1 genetic elements |
| PCT/US1999/006556 WO1999056774A1 (en) | 1998-04-30 | 1999-04-30 | Viral chimeras comprised of caev and hiv-1 genetic elements |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE284709T1 true ATE284709T1 (de) | 2005-01-15 |
Family
ID=26769556
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99919756T ATE284709T1 (de) | 1998-04-30 | 1999-04-30 | Virale chimären aus caev und hiv-1 genetischen elementen |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6602505B2 (de) |
| EP (1) | EP1073461B1 (de) |
| JP (1) | JP2002513546A (de) |
| KR (1) | KR20010074495A (de) |
| CN (1) | CN100346827C (de) |
| AT (1) | ATE284709T1 (de) |
| AU (1) | AU766264B2 (de) |
| CA (1) | CA2330618C (de) |
| DE (1) | DE69922642T2 (de) |
| IL (2) | IL139360A0 (de) |
| NZ (1) | NZ507942A (de) |
| WO (1) | WO1999056774A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6361784B1 (en) * | 2000-09-29 | 2002-03-26 | The Procter & Gamble Company | Soft, flexible disposable wipe with embossing |
| FR2979919B1 (fr) * | 2011-09-12 | 2015-12-11 | Centre Nat Rech Scient | Genomes lentiviraux chimeriques non-integratifs comme vaccins innovants contre vih-1 |
| US20130337009A1 (en) * | 2012-02-21 | 2013-12-19 | Immunogenetix Therapeutics, Inc. | Chimeric dna vaccine compositions and methods of use |
| JP2018505152A (ja) * | 2014-12-23 | 2018-02-22 | アン ブリンブル マーガレット | アミノ酸複合体及びペプチド複合体ならびにそれらの使用 |
| KR20180128915A (ko) | 2016-02-26 | 2018-12-04 | 오클랜드 유니서비시즈 리미티드 | 아미노산 및 펩티드 접합체 및 접합 방법 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5142025A (en) | 1986-08-01 | 1992-08-25 | Repligen Corporation | Recombinant HTLV-III proteins and uses thereof |
| US5256767A (en) | 1987-06-10 | 1993-10-26 | The Immune Response Corporation | Retroviral antigens |
| US5716826A (en) | 1988-03-21 | 1998-02-10 | Chiron Viagene, Inc. | Recombinant retroviruses |
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| US5851813A (en) | 1990-07-12 | 1998-12-22 | President And Fellows Of Harvard College | Primate lentivirus antigenic compositions |
| US5714374A (en) | 1990-09-12 | 1998-02-03 | Rutgers University | Chimeric rhinoviruses |
| US5770428A (en) | 1993-02-17 | 1998-06-23 | Wisconsin Alumni Research Foundation | Chimeric retrovial expression vectors and particles containing a simple retroviral long terminal repeat, BLV or HIV coding regions and cis-acting regulatory sequences, and an RNA translational enhancer with internal ribsome entry site |
| US5561064A (en) | 1994-02-01 | 1996-10-01 | Vical Incorporated | Production of pharmaceutical-grade plasmid DNA |
| FR2721618B1 (fr) | 1994-06-28 | 1996-09-13 | Centre Nat Rech Scient | Fragments d'acide nucléique et fragments peptidiques correspondants issus du génome du virus de l'arthrite et de l'encéphalite caprine (VAEC) et leurs applications. |
| US5955342A (en) | 1994-08-15 | 1999-09-21 | Connaught Laboratories Limited | Non-infectious, replication-defective, self-assembling HIV-1 viral particles containing antigenic markers in the gag coding region |
| FR2732346B1 (fr) | 1995-03-27 | 1997-05-30 | Centre Nat Rech Scient | Proteines mutees, codees par un gene env mute de lentivirus, fragments peptidiques inclus dans lesdites proteines, vecteurs d'expression exprimant lesdites proteines mutees et leurs applications |
| US5770357A (en) | 1996-03-15 | 1998-06-23 | Univ Southern California | Method of diagnosing caprine arthritis-encephalitis virus infection |
| ES2165042T3 (es) | 1996-03-15 | 2002-03-01 | Univ Southern California | Vacuna que contiene el virus de la artritis-encefalitis de cabra y utilizacion para inmunoproteccion contra la infeccion por hiv-1. |
| US6635472B1 (en) * | 1997-08-15 | 2003-10-21 | Rubicon Laboratory, Inc. | Retrovirus and viral vectors |
-
1999
- 1999-04-29 US US09/302,171 patent/US6602505B2/en not_active Expired - Lifetime
- 1999-04-30 EP EP99919756A patent/EP1073461B1/de not_active Expired - Lifetime
- 1999-04-30 DE DE69922642T patent/DE69922642T2/de not_active Expired - Lifetime
- 1999-04-30 IL IL13936099A patent/IL139360A0/xx active IP Right Grant
- 1999-04-30 JP JP2000546798A patent/JP2002513546A/ja active Pending
- 1999-04-30 AT AT99919756T patent/ATE284709T1/de not_active IP Right Cessation
- 1999-04-30 CA CA2330618A patent/CA2330618C/en not_active Expired - Fee Related
- 1999-04-30 WO PCT/US1999/006556 patent/WO1999056774A1/en active IP Right Grant
- 1999-04-30 AU AU37406/99A patent/AU766264B2/en not_active Ceased
- 1999-04-30 NZ NZ507942A patent/NZ507942A/xx not_active IP Right Cessation
- 1999-04-30 KR KR1020007012062A patent/KR20010074495A/ko not_active Application Discontinuation
- 1999-04-30 CN CNB99807912XA patent/CN100346827C/zh not_active Expired - Fee Related
-
2000
- 2000-10-30 IL IL139360A patent/IL139360A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU3740699A (en) | 1999-11-23 |
| US20010039669A1 (en) | 2001-11-08 |
| DE69922642T2 (de) | 2005-12-22 |
| EP1073461B1 (de) | 2004-12-15 |
| NZ507942A (en) | 2003-06-30 |
| CN1311689A (zh) | 2001-09-05 |
| CA2330618C (en) | 2012-07-03 |
| AU766264B2 (en) | 2003-10-09 |
| EP1073461A1 (de) | 2001-02-07 |
| CA2330618A1 (en) | 1999-11-11 |
| WO1999056774A1 (en) | 1999-11-11 |
| EP1073461A4 (de) | 2002-03-20 |
| IL139360A0 (en) | 2001-11-25 |
| CN100346827C (zh) | 2007-11-07 |
| DE69922642D1 (de) | 2005-01-20 |
| US6602505B2 (en) | 2003-08-05 |
| KR20010074495A (ko) | 2001-08-04 |
| JP2002513546A (ja) | 2002-05-14 |
| IL139360A (en) | 2007-07-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK33190A (da) | Hiv-3 retrovirus og anvendelse heraf | |
| DE69737736D1 (de) | Induktion rev- und tat-spezifischer zytotoxischer t-zellen zur prävention und behandlung einer infektion durch humanen immundefizienz-virus (hiv) | |
| SE8602981D0 (sv) | Novel medicinal use | |
| ATE135743T1 (de) | Monoklonale menschliche antikörper gegen hiv-i | |
| ATE284709T1 (de) | Virale chimären aus caev und hiv-1 genetischen elementen | |
| WO2006045616A3 (en) | β-L-N4-HYDROXYCYTOSINE DEOXYNUCLEOSIDES AND THEIR USE AS PHARMACEUTICAL AGENTS IN THE PROPHYLAXIS OR THERAPY OF VIRAL DISEASES | |
| DE3854857D1 (de) | Verhütung und behandlung einer retrovirenkrankheit | |
| ATE207364T1 (de) | Caprin arthritis-enzephalitis virus enthaltende vakzine und verwendung zur immunschutz gegen hiv- 1 infektion | |
| WO2002064154A3 (en) | Methods and compositions for inhibiting hiv-coreceptor interactions | |
| EP0328390B1 (de) | Peptidbehandlung von hartnäckigen Infektionskrankheiten | |
| EA199700353A1 (ru) | Композиция и способ для определения приобретенного синдрома иммунодефицита, способ приготовления названной композиции | |
| CA2339850A1 (en) | A non-cytolytic recombinant hiv-1 vaccine | |
| CA2249736A1 (en) | Caprine arthritis-encephalitis virus provides immunoprotection against hiv-1 infection | |
| NO982151D0 (no) | Hemoregulatoriske forbindelser | |
| FI943295A (fi) | Piliostigma thonningii -uutteet, niiden käyttö ja niitä sisältävät formuloinnit | |
| ZA88310B (en) | Peptides capable of being recognized by antibodies induced against human immunodeficiency retrovirus(hiv-virus),their applications for diagnosis of infections caused by some of these viruses and,in case,to vaccination against aids | |
| James | HIV-specific immune responses restored by HIV immunogen plus antiretroviral suppression | |
| ARLINGHAUS | Vaccines against tumor antigens |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |